Policy & governance: why the failure is structural (S4 MITO spin + “Clean Ether Act”)
This RF Safe article argues that the main barrier to addressing radiofrequency radiation (RFR) and other non-native EMFs is structural policy and governance failure rather than a lack of scientific evidence. It cites the 2021 D.C. Circuit decision in Environmental Health Trust et al. v. FCC as criticism of the FCC’s rationale for keeping 1996 RF exposure limits, and it points to the Radiation Control for Health and Safety Act of 1968 as a mandate for HHS to run a research-backed radiation control program. The piece also references the U.S. National Toxicology Program’s animal findings and frames the lack of further NTP RF studies as a policy shortcoming, while promoting an “S4 MITO spin” mechanistic framework and a proposed “Clean Ether Act.”
Key points
- Promotes the “S4 MITO spin” framework as a unifying mechanism intended to explain reported non-linear dose–response patterns and tissue-specific effects (heart, brain, endocrine, blood).
- Claims the central issue is governance: argues that policy has not kept pace with evidence on non-cancer effects, modulation/pulsation, newer technologies (Wi‑Fi, 5G), and environmental impacts.
- Cites Environmental Health Trust et al. v. FCC (2021), stating the court found the FCC’s 2019 decision to retain 1996 RF limits “arbitrary and capricious” for insufficient reasoning on non-cancer effects and other factors.
- References Public Law 90‑602 (Radiation Control for Health and Safety Act of 1968) and argues it obligates HHS to develop performance standards and support research on non-ionizing radiation from electronic products.
- Points to NTP/NIEHS animal studies as evidence of a link between 2G/3G-like RFR and certain tumors in male rats, and notes NTP/NIEHS statements that no further RFR exposure studies are planned due to system limitations/resources.
- Frames appeals to “FDA/FCC say it’s safe” as inadequate, emphasizing the article’s interpretation of the court’s critique of reliance on unexplained FDA statements.
Referenced studies & papers
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.